Applied Therapeutics Inc APLT:NASDAQ

Last Price$1.72NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/13/22

Today's Change-0.04(2.27%)
Bid (Size)$1.80 (1)
Ask (Size)$1.85 (20)
Day Low / High$1.71 - 1.93
Volume132.9 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 05/13/2022

 

Applied Therapeutics Inc ( NASDAQ )

Price: $1.72
Change: -0.04 (2.27%)
Volume: 132.9 K
4:00PM ET 5/13/2022
 
 

Novan Inc ( NASDAQ )

Price: $2.39
Change: +0.03 (1.27%)
Volume: 92.3 K
4:00PM ET 5/13/2022
 
 

Tyme Technologies Inc ( NASDAQ )

Price: $0.26
Change: +0.02 (8.33%)
Volume: 377.3 K
3:59PM ET 5/13/2022
 
 

CASI Pharmaceuticals Inc ( NASDAQ )

Price: $0.35
Change: +0.04 (11.66%)
Volume: 218.6 K
4:00PM ET 5/13/2022
 
 

AIM ImmunoTech Inc ( NYSE MKT LLC )

Price: $0.99
Change: +0.03 (2.92%)
Volume: 98.9 K
8:00PM ET 5/13/2022
 

Read more news Recent News

--Truist Securities Adjusts Price Target on Applied Therapeutics to $6 From $85, Reiterates Buy Rating
8:39AM ET 4/13/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Barclays Adjusts Price Target on Applied Therapeutics to $2.50 From $7, Keeps Equalweight Rating
7:03AM ET 3/21/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Citigroup Adjusts Applied Therapeutics' Price Target to $30 From $38, Reiterates Buy Rating
11:24AM ET 1/05/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Goldman Sachs Adjusts Price Target on Applied Therapeutics to $3 From $10, Reiterates Sell Rating
8:29AM ET 1/05/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

View all Commentary and Analysis

The Zacks Analyst Blog Highlights Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma
7:28AM ET 5/13/2022 Zacks

Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma...

Applied Therapeutics (APLT) Investor Presentation - Slideshow
1:34AM ET 3/17/2022 Seeking Alpha

Applied Therapeutics: Buying This Beaten-Down, Undervalued Rare Disease Company's Stock
8:35AM ET 1/19/2022 Seeking Alpha

Wall Street Breakfast: What Moved Markets
5:57AM ET 1/08/2022 Seeking Alpha

Company Profile

Business DescriptionApplied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY. View company web site for more details
Address545 5th Avenue
New York, New York 10017
Phone+1.212.220.9226
Number of EmployeesN/A
Chairman, President, CEO & SecretaryShoshana Shendelman
Senior Vice President-FinanceChids Mahadevan
Chief Medical OfficerRiccardo Perfetti
Chief Commercial OfficerAdam Hansard

Company Highlights

Price Open$1.84
Previous Close$1.76
52 Week Range$1.45 - 25.59
Market Capitalization$45.1 M
Shares Outstanding26.2 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/11/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$4.11
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-106.41%

Analyst Ratings as of 04/11/2022

Buy
4
Overweight
1
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset